Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Baxter
Cipla
Fish and Richardson
Deloitte
Accenture
Mallinckrodt
AstraZeneca
US Army
Cerilliant
Harvard Business School

Generated: February 19, 2018

DrugPatentWatch Database Preview

Details for Patent: 6,068,833

« Back to Dashboard

Summary for Patent: 6,068,833
Title: Methods and compositions for treating pulmonary disorders using optically pure (R,R) formoterol
Abstract:A method and composition are disclosed utilizing the pure (R,R) isomer of formoterol, which is a potent bronchodilator with reduced adverse effects, having a low incidence of the development of tolerance and having increased duration of action.
Inventor(s): Aberg; Gunnar (Westborough, MA), Morley; John (Kew, GB)
Assignee: Sepracor Inc. (Marlborough, MA)
Application Number:09/136,109
Patent Claim Types:
see list of patent claims
Use; Dosage form; Delivery; Composition;

Drugs Protected by US Patent 6,068,833

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 6,068,833

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom9107196Apr 05, 1991

International Patents Family Members for US Patent 6,068,833

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
United Kingdom 9207363 ➤ Sign Up
United Kingdom 2255503 ➤ Sign Up
France 2674751 ➤ Sign Up
United Kingdom 9107196 ➤ Sign Up
United Kingdom 2289842 ➤ Sign Up
United Kingdom 9517463 ➤ Sign Up
Italy RM920237 ➤ Sign Up
Italy 1254317 ➤ Sign Up
Switzerland 686869 ➤ Sign Up
Switzerland 685672 ➤ Sign Up
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Julphar
Healthtrust
Harvard Business School
Cipla
Baxter
Johnson and Johnson
Queensland Health
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot